Study identification

EU PAS number

EUPAS1000000716

Study ID

1000000716

Official title and acronym

DARWIN EU® - Incidence, period prevalence, and characterisation of individuals with paediatric pulmonary arterial hypertension

DARWIN EU® study

Yes

Study countries

Denmark
Finland
France
Germany
Norway
Sweden

Study description

The intention of the study is to investigate the occurrence of pulmonary arterial hypertension (PAH) in paediatric patients by age group and to understand the size of this population in various EU countries. Additionally, the study aims to characterise the disease and treatments use in the paediatric PAH population in a real-world setting. This study can therefore be used in any future paediatric PAH related regulatory procedures.

Study status

Ongoing
Research institutions and networks

Institutions

Networks

Contact details

Nicholas Hunt

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Sources of funding
EMA
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable